Affinage

DCHS1

Protocadherin-16 · UniProt Q96JQ0

Length
3298 aa
Mass
346.2 kDa
Annotated
2026-04-28
21 papers in source corpus 15 papers cited in narrative 16 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

DCHS1 is a large transmembrane protocadherin that functions as a ligand for the FAT4 receptor, forming heterophilic trans-complexes at cell boundaries to regulate planar cell polarity, Hippo pathway activity, and tissue morphogenesis across multiple developmental contexts. DCHS1–FAT4 signaling suppresses YAP/TEAD transcriptional activity to control progenitor proliferation and differentiation in the neuroepithelium, kidney, bone, and cardiac valves, though in certain contexts such as the sclerotome it regulates proliferation independently of YAP/TAZ (PMID:21303848, PMID:24056717, PMID:27381226, PMID:31358536). The DCHS1 intracellular domain is required for polarized subcellular localization and downstream Hippo signaling, and DCHS1 undergoes proteolytic cleavage generating intracellular C-terminal fragments with dynamic tissue-specific localization during cardiac development (PMID:41972678, PMID:40497950). Loss-of-function mutations in DCHS1 cause mitral valve prolapse by reducing protein stability and disrupting cell migration, and deletion of the intracellular domain produces Van Maldergem-like craniofacial and neurodevelopmental defects (PMID:26258302, PMID:41972678).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 2011 High

    Establishing that DCHS1 functions as a FAT4 ligand in a conserved signaling pathway resolved the vertebrate identity of the Drosophila Dachsous–Fat system and showed that both genes operate in the same pathway across multiple organs.

    Evidence Gene-targeted mouse mutants for Dchs1 and Fat4, with single and double mutant phenotypic comparison and reciprocal protein staining

    PMID:21303848

    Open questions at the time
    • Biochemical demonstration of direct DCHS1–FAT4 binding was not provided
    • Downstream signaling effectors were not identified
  2. 2013 High

    Placing DCHS1–FAT4 upstream of YAP in genetic epistasis established that this protocadherin pair signals through the Hippo pathway to control neural progenitor proliferation and differentiation.

    Evidence Concurrent Yap knockdown rescued the increased progenitor numbers caused by Dchs1/Fat4 loss in mouse neuroepithelium

    PMID:24056717

    Open questions at the time
    • Biochemical mechanism linking DCHS1–FAT4 to YAP phosphorylation was not defined
    • Whether Hippo dependence is universal across all DCHS1-dependent tissues was unknown
  3. 2014 High

    Demonstrating that Fat4 and Dchs1 are expressed in complementary gradients and required for collective neuronal migration revealed that DCHS1–FAT4 provides graded planar polarity cues distinct from Frizzled-PCP.

    Evidence Mouse genetics with mosaic inactivation and in vivo neuronal migration assays in hindbrain facial branchiomotor neurons

    PMID:24998526

    Open questions at the time
    • How DCHS1 gradient information is transduced intracellularly to orient migration was not resolved
  4. 2015 High

    Identifying DCHS1 mutations as causative for familial mitral valve prolapse linked this protocadherin to human cardiovascular disease and showed that missense mutations reduce protein stability.

    Evidence Zebrafish morpholino knockdown with rescue, protein stability assays in patient-derived MVICs, and Dchs1+/- mouse model

    PMID:26258302

    Open questions at the time
    • Precise structural basis for reduced protein stability was not determined
    • Whether valve disease arises from impaired FAT4 binding or impaired intracellular signaling was unclear
  5. 2015 High

    Tissue-specific deletion studies in the kidney established that DCHS1 localizes in a polarized manner at the stromal–cap mesenchyme interface and acts cell-autonomously in cap mesenchyme, while FAT4 acts non-autonomously from the stroma — and that this renal function can be YAP-independent.

    Evidence Conditional deletions, double mutant epistasis with Yap in cap mesenchyme, antibody staining of genetic mosaics in mouse kidney

    PMID:26116661 PMID:26116666

    Open questions at the time
    • The alternative downstream effector in the YAP-independent renal pathway was not identified
    • Whether DCHS1 and DCHS2 are fully redundant in cap mesenchyme was not resolved
  6. 2016 High

    Studies of sternum and vertebral morphogenesis showed that DCHS1–FAT4 directs cell orientation and intercalation in mesenchymal condensations, and that in the sclerotome it regulates proliferation independently of YAP and TAZ, revealing context-dependent effector usage.

    Evidence Dchs1/Fat4 mutant mice with cell orientation assays in pre-chondrogenic mesenchyme; Fat4;Yap and Fat4;Taz double mutant analysis in sclerotome

    PMID:27145737 PMID:27381226

    Open questions at the time
    • The Hippo-independent effector downstream of DCHS1–FAT4 in sclerotome was not identified
    • Molecular link between DCHS1 and cytoskeletal remodeling underlying cell intercalation was not defined
  7. 2019 High

    Demonstrating that DCHS1–FAT4 loss elevates YAP-TEAD activity and differentially alters YAP–Runx2 and TAZ–Runx2 complexes in osteoblasts provided the first mechanistic link between this pathway and a lineage-specific transcription factor.

    Evidence Dchs1/Fat4 mutant mouse osteoblast analysis with Runx2 transcriptional reporter assays and co-complex analysis

    PMID:31358536

    Open questions at the time
    • Whether DCHS1 directly regulates LATS kinase activity was not tested
    • Structural basis of YAP–Runx2 versus TAZ–Runx2 differential regulation was not resolved
  8. 2022 Medium

    Identification of LIX1L as a cytoplasmic adaptor linking the DCHS1 intracellular domain to septins and actin provided the first molecular bridge between DCHS1 adhesion and cytoskeletal organization in valve tissue.

    Evidence Co-immunoprecipitation and pulldown with actin organization assays in mouse and cell culture models

    PMID:35200715

    Open questions at the time
    • Interaction has not been independently confirmed by a second laboratory
    • Whether the DCHS1–LIX1L–SEPT9 axis functions outside cardiac valve tissue is unknown
    • Direct binding stoichiometry and structural details are lacking
  9. 2025 Medium

    Multiple 2025 studies defined the functional importance of the DCHS1 intracellular domain: it is required for polarized localization and Hippo signaling in the brain, undergoes proteolytic cleavage during cardiac development, and its trans-complex dynamics with FAT4 are controlled by the Fat4 ICD and actin polymerization.

    Evidence DCHS1 ICD deletion mouse model with pYAP1:YAP1 ratio measurements; Dchs1-HA knock-in mouse with western blotting revealing cleavage fragments; quantitative live imaging of Fat4/Dchs1 complexes with Fat4 ICD deletion and actin inhibition

    PMID:39955614 PMID:40497950 PMID:41972678

    Open questions at the time
    • Identity of the protease(s) cleaving DCHS1 is unknown
    • Whether DCHS1 cleavage fragments have signaling functions remains untested
    • How Fat4 ICD-dependent trans-endocytosis of DCHS1 connects to downstream Hippo effectors is not established
  10. 2025 Medium

    Phospho-Cx43 (S282) was shown to upregulate DCHS1 transcription, placing DCHS1 downstream of gap junction signaling and upstream of YAP phosphorylation in an antifibrotic cardiac pathway.

    Evidence mRNA sequencing, angiotensin II cardiac fibrosis model in vivo, TGF-β1 myofibroblast model in vitro, Cx43 S282A phosphomutant

    PMID:39938686

    Open questions at the time
    • Mechanism by which Cx43 phosphorylation regulates DCHS1 transcription is unknown
    • Whether this pathway operates outside the cardiac fibrosis context is untested
    • Single-laboratory finding not yet independently replicated

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key unresolved questions include the identity of the protease(s) that cleave DCHS1, the signaling function (if any) of DCHS1 cleavage fragments, the molecular mechanism linking DCHS1–FAT4 to LATS kinase activation, and the nature of the Hippo-independent downstream effector operating in certain tissues.
  • No structural model of the DCHS1–FAT4 interface exists
  • The Hippo-independent effector downstream of DCHS1–FAT4 in sclerotome and kidney remains unidentified
  • Whether DCHS1 proteolytic fragments function as transcriptional regulators is untested

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098631 cell adhesion mediator activity 4 GO:0098772 molecular function regulator activity 4
Localization
GO:0005886 plasma membrane 4 GO:0005856 cytoskeleton 1
Pathway
R-HSA-1266738 Developmental Biology 7 R-HSA-162582 Signal Transduction 6
Partners
EPHA4FAT4LIX1LSEPT9YAP1

Evidence

Reading pass · 16 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2011 DCHS1 functions as a ligand for FAT4 receptor in a conserved intercellular signaling pathway regulating planar cell polarity and Hippo signaling; Dchs1 and Fat4 single mutants and double mutants have similar phenotypes throughout multiple organs, and mutation of either gene increases protein staining for the other, consistent with a ligand-receptor relationship. Gene-targeted mutation in mice, phenotypic comparison of single and double mutants, protein staining Development (Cambridge, England) High 21303848
2013 DCHS1 and FAT4 act upstream of YAP (a transcriptional effector of the Hippo signaling pathway) to regulate neural progenitor proliferation and differentiation; concurrent knockdown of Yap countered the increased progenitor numbers and reduced differentiation caused by Dchs1/Fat4 knockdown in mouse neuroepithelium. Genetic epistasis (concurrent knockdown of Yap rescues Dchs1/Fat4 loss-of-function phenotype), mouse embryonic neuroepithelium knockdown Nature genetics High 24056717
2015 DCHS1 mutations reduce protein stability; missense mutations in DCHS1 segregating with mitral valve prolapse (MVP) result in reduced DCHS1 protein levels in zebrafish, cultured cells, and patient-derived mitral valve interstitial cells (MVICs). DCHS1 deficiency in MVICs leads to altered cell migration and cellular patterning. Morpholino knockdown in zebrafish with rescue experiments (wild-type vs. mutant DCHS1 mRNA), protein stability assays in cultured cells and patient-derived MVICs, Dchs1+/- mouse model Nature High 26258302
2015 FAT4 acts non-autonomously in the renal stroma to bind DCHS1/DCHS2 in the condensing mesenchyme (cap mesenchyme) to restrict nephron progenitor self-renewal; DCHS1 and its paralog DCHS2 function in a partially redundant fashion, and FAT4 regulation of cap mesenchyme is independent of YAP. Tissue-specific conditional deletions, Six2-/-;Fat4-/- double mutants, Yap conditional knockout in cap mesenchyme of Fat4-null mice, electron microscopy, gene expression analysis Development (Cambridge, England) High 26116661
2015 DCHS1 protein localizes in a polarized manner within cap mesenchyme cells, accumulating at the interface with stromal cells, implicating direct interaction with a stromal protein (FAT4); genetically, DCHS1 is required specifically within cap mesenchyme cells for nephron morphogenesis and ureteric bud branching. Antibody staining of genetic mosaics, tissue-specific genetic analysis, Dchs1 mutant mouse phenotyping Development (Cambridge, England) High 26116666
2014 Fat4 and Dchs1 are expressed in complementary gradients in the hindbrain and are required intrinsically within facial branchiomotor (FBM) neurons and extrinsically within the neuroepithelium for collective tangential neuronal migration and planar cell polarity; Fat-PCP and Fz-PCP regulate FBM neuron migration along orthogonal axes, and disruption of Dchs1 gradients by mosaic inactivation alters FBM neuron polarity and migration. Mouse genetics (Fat4 and Dchs1 mutants), mosaic inactivation, in vivo neuronal migration assays, PCP marker analysis Current biology : CB High 24998526
2016 The Dchs1-Fat4 planar cell polarity pathway controls cell orientation in early skeletal condensation to define sternum shape via cell intercalation; Fat4 and Dchs1 establish polarized cell behavior intrinsically within the mesenchyme, and alterations in Dchs1-Fat4 activity drive simultaneous narrowing, thickening, and elongation of the sternum. Dchs1 and Fat4 mutant mouse analysis, cell orientation and intercalation assays in pre-chondrogenic mesenchyme Nature communications High 27145737
2016 Fat4-Dchs1 signaling regulates cell proliferation in the developing vertebrae independently of Yap and Taz; Fat4;Yap and Fat4;Taz double mutant analysis and expression of transcriptional target Ctgf indicate that Fat4-Dchs1 controls sclerotome cell proliferation through a novel Hippo-independent mechanism. Fat4 and Dchs1 mutant mice, Fat4;Yap and Fat4;Taz double mutants, Ctgf expression analysis, cell polarity and proliferation assays in sclerotome Development (Cambridge, England) High 27381226
2019 Dchs1-Fat4 signaling regulates osteoblast differentiation by suppressing Yap-Tead activity; loss of Dchs1-Fat4 increases Yap-Tead activity and Yap-dependent osteoprogenitor proliferation while delaying differentiation. Yap and Taz differentially regulate Runx2 transcriptional activity, and both Yap-Runx2 and Taz-Runx2 complex activities are altered in Dchs1/Fat4 mutant osteoblasts. Dchs1/Fat4 mutant mouse analysis, Yap and Taz expression and activity assays, Runx2 transcriptional reporter assays, co-complex analysis Development (Cambridge, England) High 31358536
2022 DCHS1-based cell adhesions interact with the septin-actin cytoskeleton through cytoplasmic protein LIX1L (Lix1-Like); the DCHS1-LIX1L-SEPT9 axis interacts with and promotes filamentous actin organization to direct cell-ECM alignment and valve tissue shape. Biochemical techniques (co-immunoprecipitation, pulldown), mouse and cell culture models, actin organization assays Journal of cardiovascular development and disease Medium 35200715
2025 The Fat4 intracellular domain (ICD) controls internalization of Fat4/Dchs1 complexes; removing the Fat4 ICD reduces trans-endocytosis of Dchs1 into Fat4 cells and reduces boundary accumulation of Fat4/Dchs1 complexes. Actin polymerization is required for boundary accumulation of Fat4/Dchs1 complexes but does not correlate with local Fat4/Dchs1 distribution. Quantitative live imaging of Fat4/Dchs1 complex dynamics, ICD deletion constructs, actin polymerization inhibition Biophysical journal Medium 39955614
2025 Cx43 S282 phosphorylation upregulates DCHS1 gene expression, which in turn activates YAP phosphorylation and inhibits YAP/TEAD signaling to suppress cardiac fibrosis; DCHS1 acts downstream of phospho-Cx43 and upstream of YAP phosphorylation in this antifibrotic pathway. mRNA sequencing (GSEA), in vivo angiotensin II cardiac fibrosis model, in vitro TGF-β1 myofibroblast model, lentiviral overexpression and adenoviral injection, Cx43 S282A phosphomutant Biochimica et biophysica acta. Molecular cell research Medium 39938686
2025 The DCHS1 intracellular domain (ICD) is required for polarized subcellular localization within the subventricular zone and for Hippo pathway activity; deletion of the ICD reduces pYAP1:YAP1 ratio and increases Ki67+ neuronal proliferation in periventricular regions, causing Van Maldergem-like craniofacial and neurodevelopmental defects. DCHS1 ICD deletion mouse model (Dchs1Δ), immunostaining, western blotting, pYAP1:YAP1 ratio measurements, Ki67 proliferation assays Cells Medium 41972678
2025 DCHS1 undergoes proteolytic cleavage generating intracellular C-terminal fragments; in cardiac development, DCHS1 displays dynamic subcellular localization shifting from epicardial/endocardial surfaces at earlier embryonic stages to compact myocardium in later fetal and neonatal stages, and forms polarized extensions bridging endothelial and non-myocyte cells. Dchs1-HA knock-in mouse model, immunohistochemistry, western blotting, single-cell transcriptomics Cells Medium 40497950
2025 A modern human-specific missense mutation in DCHS1 disrupts an N-glycosylation site; introduction of the ancestral (Neanderthal) DCHS1 variant into human iPSCs via CRISPR/Cas9 editing expands striatal progenitors at the expense of neocortical progenitors in neural organoids. EPHA4 (ephrin receptor) is identified as a binding partner of DCHS1, and DCHS1 modulates EPHA4-ephrin signaling. CRISPR/Cas9 editing of hiPSCs, human cerebral organoids, pulldown/binding partner identification of EPHA4 bioRxivpreprint Medium 40463223
2024 DCHS1 neurons derived from patients with periventricular heterotopia show decreased spike threshold due to increased somatic voltage-gated sodium channels; morphological rescue of DCHS1 neurons is achieved by wild-type DCHS1 expression, confirming DCHS1's direct role in neuronal morphology and electrophysiological properties. Human cerebral organoids from DCHS1 mutation patients, silicon probe recordings, patch-clamp electrophysiology, morphological reconstruction, wild-type DCHS1 rescue expression bioRxivpreprint Medium

Source papers

Stage 0 corpus · 21 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2013 Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nature genetics 213 24056717
2011 Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development. Development (Cambridge, England) 167 21303848
2015 Mutations in DCHS1 cause mitral valve prolapse. Nature 157 26258302
2015 Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. Development (Cambridge, England) 74 26116661
2005 Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila. Developmental dynamics : an official publication of the American Association of Anatomists 74 16059920
2015 Fat4/Dchs1 signaling between stromal and cap mesenchyme cells influences nephrogenesis and ureteric bud branching. Development (Cambridge, England) 63 26116666
2014 Regulation of neuronal migration by Dchs1-Fat4 planar cell polarity. Current biology : CB 61 24998526
2016 Dchs1-Fat4 regulation of polarized cell behaviours during skeletal morphogenesis. Nature communications 43 27145737
2019 Dchs1-Fat4 regulation of osteogenic differentiation in mouse. Development (Cambridge, England) 28 31358536
2016 Fat4-Dchs1 signalling controls cell proliferation in developing vertebrae. Development (Cambridge, England) 26 27381226
2017 Deleterious variants in DCHS1 are prevalent in sporadic cases of mitral valve prolapse. Molecular genetics & genomic medicine 13 29224215
2022 DCHS1, Lix1L, and the Septin Cytoskeleton: Molecular and Developmental Etiology of Mitral Valve Prolapse. Journal of cardiovascular development and disease 10 35200715
2024 A high-calcium environment induced ectopic calcification of renal interstitial fibroblasts via TFPI-2-DCHS1-ALP/ENPP1 axis to participate in Randall's plaque formation. Urolithiasis 5 39196305
2024 Mutation in mitral valve prolapse susceptible gene DCHS1 causes familial mitral annular disjunction. Journal of medical genetics 4 37399314
2020 DCHS1 DNA copy number loss associated with pediatric urinary tract infection risk. Innate immunity 3 32295462
2025 Connexin 43 dephosphorylation mediates the Dchs1/YAP/TEAD signaling pathway to induce cardiac fibrosis. Biochimica et biophysica acta. Molecular cell research 2 39938686
2025 Fat4 intracellular domain controls internalization of Fat4/Dchs1 planar polarity membrane complexes. Biophysical journal 2 39955614
2025 DCHS1 Modulates Forebrain Proportions in Modern Humans via a Glycosylation Change. bioRxiv : the preprint server for biology 1 40463223
2025 Dynamic Expression and Functional Implications of the Cell Polarity Gene, Dchs1, During Cardiac Development. Cells 1 40497950
2022 Neonatal lethality of mouse A/J-7SM consomic strain is caused by an insertion mutation in the Dchs1 gene. Mammalian genome : official journal of the International Mammalian Genome Society 1 36434174
2026 Loss of the DCHS1 Intracellular Domain Expands Neurogenic Proliferation and Generates Van Maldergem-like Neurodevelopmental Defects. Cells 0 41972678